Physician profile
Matthew Brown
NPI 1245572890
$4,579.46
in general payments reported to CMS, 2019-2025
44 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $87.32 · 2021: $2,624 · 2022: $409 · 2023: $315 · 2024: $657 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southtech Orthopedics | $2,400.00 | 2021 | |
| Nevro Corp. | $249.60 | 2022-2024 | Senza |
| Stryker Corporation | $245.07 | 2019-2024 | Augment Injectable, Variax, Ortholoc 2 Lapifuse |
| Zimmer Biomet Holdings, INC. | $134.94 | 2021 | |
| Bioventus LLC | $111.32 | 2019-2025 | Theragenesis Bilayer Wound Matrix, Exogen Ultrasound Bone Healing System |
| Ucb, INC. | $97.97 | 2022-2023 | Cimzia |
| Ani Pharmaceuticals, INC. | $93.53 | 2024 | Purified Cortrophin Gel |
| Mimedx Group, INC. | $88.93 | 2024-2025 | |
| Kerecis Limited | $85.83 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $71.20 | 2021-2024 | Affinity, Puraply Franchise |
| Treace Medical Concepts, INC. | $68.45 | 2024-2025 | |
| Wright Medical Technology, INC. | $67.18 | 2019-2020 | |
| Paragon 28, INC. | $60.78 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $58.82 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $54.16 | 2023-2025 | Nuzyra |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.